Nitric oxide donors suppress chemokine production by keratinocytes in vitro and in vivo

American Journal of Pathology

Volumn 161, Issue 4, 2002, Pages 1409-1418

  Giustizieri, Maria Laura ^a   Albanesi, Cristina ^a   Scarponi, Claudia ^a   De Pità, Ornella ^a   Girolomoni, Giampiero ^a  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD3 ANTIGEN; CHEMOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; NITRIC OXIDE DONOR; RANTES; S NITROSOGLUTATHIONE; STAT1 PROTEIN; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; EPIDERMIS; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS;

EID: 0036792569     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64416-1     Document Type: Article

References (41)

1. Albanesi C, Scarponi C, Sebastiani S, Cavani A, Federici M, Sozzani S, Girolomoni G: A cytokine-to-chemokine axis between T lymphocytes and keratinocytes can favor Th1 cell accumulation in chronic inflammatory skin diseases. J Leukoc Biol 2001, 70:617-623
2. Sebastiani S, Albanesi C, De Pità O, Puddu P, Cavani A, Girolomoni G: The role of chemokines in allergic contact dermatitis. Arch Dermatol Res 2002, 293:552-559
3. Albanesi C, Cavani A, Girolomoni G: IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokines production in human keratinocytes: synergistic or antagonistic effects with IFN-γ and TNF-α. J Immunol 1999, 162:494-502
4. Albanesi C, Scarponi C, Sebastiani S, Cavani A, Federici M, De Pità O, Puddu P, Girolomoni G: IL-4 enhances keratinocytes expression of CXCR3 agonistic chemokines. J Immunol 2000, 165:1395-1402
5. Nickoloff BJ, Mitra RS, Varani J, Dixit VM, Polverini PJ: Aberrant production of interleukin-8 and thrombospondin-1 by psoriatic keratinocytes mediates angiogenesis. Am J Pathol 1994, 144:820-828
6. Gillitzer R, Wolff K, Tong D, Müller C, Yoshimura T, Hartmann AA, Stingl G, Berger R: MCP-1 mRNA expression in basal keratinocytes of psoriatic lesions. J Invest Dermatol 1993, 101:127-131
7. Gottlieb AB, Luster AD, Posnett DN, Carter DM: Detection of a γ interferon-induced protein IP-10 in psoriatic plaques. J Exp Med 1998, 168:941-948
8. Giustizieri ML, Mascia F, Frezzolini A, De Pità O, Chinni LM, Giannetti A, Girolomoni G, Pastore S: Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokines production profile in response to T cell-derived cytokines. J Allergy Clin Immunol 2001, 107:871-877
9. Sallusto F, Mackay CR, Lanzavecchia A: The role of chemokine receptors in primary, effector, and memory immune response. Annu Rev Immunol 2000, 18:593-620
10. Barker JN, Sarma V, Mitra RS, Dixit VM, Nickoloff BJ: Marked synergism between tumor necrosis factor factor-alpha and interferongamma in regulation of keratinocyte-derived adhesion molecules and chemotactic factors. J Clin Invest 1990, 85:605-608
11. + T cell subset against keratinocytes. J Immunol 2000, 165:3058-3064
12. Ormerod AD, Weller R, Copeland P, Benjamin N, Ralston SH, Grabowksi P, Herriot R: Detection of nitric oxide and nitric oxide synthases in psoriasis. Arch Dermatol Res 1998, 290:3-8
13. Ormerod AD, Dwyer CM, Reid CM, Copeland P, Thomson WD: Inducible nitric oxide synthase demonstrated in irritant and allergic contact dermatitis. Acta Derm Venereol (Stockh) 1997, 77:436-440
14. Rowe A, Farrel AM, Bunker CB: Constitutive endothelial and inducible nitric oxide synthase in inflammatory dermatoses. Br J Dermatol 1997, 136:18-23
15. Sirsjo A, Karlsson M, Gidlof A, Rollman O, Torma H: Increased expression of inducibile nitric oxide synthase in psoriatic skin and cytokine-stimulated cultured keratinocytes. Br J Dermatol 1996, 134:643-648
16. Qureshi AA, Hosoi J, Xu S, Takashima A, Granstein RD, Lerner EA: Langerhans cells express inducible nitric oxide synthase and produce nitric oxide. J Invest Dermatol 1996, 107:815-821
17. Bodgan C: Nitric oxide and the immune response. Nat Immunol 2001, 2:907-916
18. Zouki C, Jozsef L, Ouellet S, Paquette Y, Filep JG: Peroxynitrite mediates cytokine-induced IL-8 gene expression and production by human leukocytes. J Leukoc Biol 2001, 69:815-824
19. Romagnani P, Lazzeri E, Lasagni L, Mavilia C, Beltrame C, Francalanci M, Rotondi M, Annunziato F, Maurenzig L, Coami L, Galli G, Salvadori M, Maggi E, Seri M: IP-10 and Mig production by glomerular cells in human proliferative glomerulonephritis and regulation by nitric oxide. J Am Soc Nephrol 2002, 13:53-64
20. Wetzler C, Kämpfer H, Pfeilschifter J, Frank S: Keratinocyte-derived chemotactic cytokines: expressional modulation by nitric oxide in vitro and during cutaneous wound repair in vivo. Biochem Biophys Res Commun 2000, 274:689-696
21. Frank S, Kämpfer H, Wetzler C, Stallmeyer B, Pfeilschifter J: Large induction of the chemotactic cytokine RANTES during cutaneous wound repair: a regulatory role for nitric oxide in keratinocyte-derived RANTES expression. Biochem J 2000, 347:265-273
22. Spiecker M, Darius H, Kaboth K, Hübner F, Liao JK: Differential regulation of endothelial cell adhesion molecule expression by nitric oxide donors and antioxidants. J Leukoc Biol 1998, 63:732-739
23. Grisham MB, Granger DN, Lefer DJ: Modulation of leukocyte-endothelial interactions by reactive metabolites of oxygen and nitrogen; relevance to ischemic heart disease. Free Radic Biol Med 1998, 25:404-433
24. Pastore S, Fanales-Belasio E, Albanesi C, Chinni LM, Giannetti A, Girolomoni G: Granulocyte macrophage colony-stimulating factor is overproduced by keratinocytes in atopic dermatitis. Implications for sustained dendritic cell activation in the skin. J Clin Invest 1997, 99:3009-3017
25. Percival MD, Ouellet M, Campagnolo C, Claveau D, Li C: Inhibition of cathepsin K by nitric oxide donors: evidence for the formation of mixed disulfides and a sulfenic acid. Biochemistry 1999, 38:13574-13583
26. Gosh S, May MJ, Kopp EB: NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Cell Biol 1998, 16:225-260
27. Foletta VC, Segal DH, Cohen DR: Transcriptional regulation in the immune system: all roads lead to AP1. J Leukoc Biol 1997, 63:139-152
28. Horwarth CM, Darnell JE: The state of the STATS: recent developments in the study of signal transduction to the nucleus. Curr Opin Cell Biol 1997, 9:233-239
29. Bos JD, De Rie MA: The pathogenesis of psoriasis: immunological facts and speculations. Immunol Today 1999, 20:40-46
30. Nickoloff BJ: Skin innate immune system in psoriasis: friend or foe? J Clin Invest 1999, 104:1161-1164
31. Nickoloff BJ, Schröder JM, von den Driesch P, Raychaudhuri SP, Farber EM, Boehncke WH, Morhenn VB, Rosenberg EW, Schön MP, Holick MF: Is psoriasis a T-cell disease? Exp Dermatol 2000, 9:359-375
32. Asadullah K, Volk H-D, Sterry W: Novel immunotherapies for psoriasis. Trends Immunol 2002, 23:47-53
33. Dieu-Nosjean MC, Massacrier C, Homey B, Vanbervliet B, Pin JJ, Vicari A, Lebecque S, Dezutter-Dambuyant C, Schmitt D, Zlotnik A, Caux C: Macrophage inflammatory protein 3α is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting Langerhans cell precursors. J Exp Med 2000, 191:705-717
34. Homey B, Dieu-Nosjean MC, Wiesenborn A, Massacrier C, Pin JJ, Oldham E, Catron D, Buchanan ME, Muller A, deWaal Malefyt R, Deng G, Orozco R, Ruzicka T, Lehmann P, Lebecque S, Caux C, Zlotnik A: Up-regulation of macrophage inflammatory protein-3 α/CCL20 and CC chemokine receptor 6 in psoriasis. J Immunol 2000, 164:6621-6632
35. Laroux FS, Pavlick KP, Hines IN, Kawachi S, Harada H, Bharwani S, Hoffman JM, Grisham MB: Role of nitric oxide in inflammation. Acta Physiol Scand 2001, 173:113-118
36. Sato E, Simpson KL, Grisham MB, Koyama S, Robbins RA: Reactive nitrogen and oxygen species attenuate interleukin-8-induced neutrophil chemotactic activity in vitro. J Biol Chem 2000, 275:10826-10830
37. Cherta RP, Ganu RK: Stromal cell-derived factor 1α-induced chemotaxis in T cells is mediated by nitric oxide signaling pathways. J Immunol 2001, 166:3067-3074
38. Karvonen SL, Korkiamaki T, Yla-Outinen H, Nissinen M, Teerikangas H, Pummi K, Karvonen J, Peltonen J: Psoriasis and altered calcium metabolism: downregulated capacitative calcium influx and defective calcium-mediated cell signaling in cultured psoriatic keratinocytes. J Invest Dermatol 2000, 114:693-700
39. Haase I, Hobbs RM, Romero MR, Broad S, Watt FM: A role for mitogen-activated protein-kinase activation by integrins in the pathogenesis of psoriasis. J Clin Invest 2001, 108:527-536
40. Yasumoto K, Okamoto S, Mukaida N, Murakami S, Mai M, Matsushima K: Tumor necrosis factor alpha and interferon gamma synergistically induce interleukin 8 production in a human gastric cancer cell line through acting concurrently on AP-1 and NF-κB-like binding sites of the interleukin 8 gene. J Biol Chem 1992, 267:22506-22511
41. Rossi A, Catani MV, Candi E, Bernassola F, Puddu P, Melino G: Nitric oxide inhibits cornified envelope formation in human keratinocytes by inactivating transglutaminases and activating protein 1. J Invest Dermatol 2000, 115:731-739